Abstract 357: A glial origin for medulloblastoma and inhibition of MYCN stabilization.
Sara Bolin(Uppsala University), Fredrik J. Swartling(Uppsala University), William A. Weiss(University of California, San Francisco), Sanna‐Maria Hede(Uppsala University), Anders I. Persson(University of California, San Francisco), Justin Chen(Stanford University), Jasmine Lau(UCSF Helen Diller Family Comprehensive Cancer Center), Vasil Savov(Uppsala University)
Cited by 0
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
|BMC Medicine|2008|948
Targeted expression of MYCN causes neuroblastoma in transgenic mice
|The EMBO Journal|1997|870
Neuroblastoma and MYCN
|Cold Spring Harbor Perspectives in Medicine|2013|642
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
|Journal of Clinical Oncology|2013|488